Colon cancer metastasis: MACC1 and Met as metastatic pacemakers

International Journal of Biochemistry and Cell Biology

Volumn 41, Issue 12, 2009, Pages 2356-2359

  Arlt, Franziska ^a   Stein, Ulrike ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Colon cancer; MACC1; Met; Metastasis; Prognosis

Indexed keywords

PROTEIN MACC1; REGULATOR PROTEIN; SCATTER FACTOR RECEPTOR; UNCLASSIFIED DRUG;

CANCER GROWTH; CANCER INVASION; CANCER RISK; CANCER STAGING; CANCER THERAPY; COLON CANCER; DRUG TARGETING; GENE EXPRESSION; GENE MUTATION; GENOMIC INSTABILITY; HUMAN; METASTASIS; PATHOGENESIS; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SHORT SURVEY; TUMOR GROWTH;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CLINICAL TRIALS AS TOPIC; COLONIC NEOPLASMS; DISEASE PROGRESSION; HUMANS; MUTATION; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-MET; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 70350337085     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2009.08.001     Document Type: Short Survey

References (26)

1. Baylin S.B., and Ohm J.E. Epigenetic gene silencing in cancer-a mechanism for early oncogenic pathway addiction?. Nat Rev Cancer 6 (2006) 107-116
2. Bendardaf R., Lamlum H., and Pyrhonen S. Prognostic and predictive molecular markers in colorectal carcinoma. Anticancer Res 24 (2004) 2519-2530
3. Bernards R., and Weinberg R.A. A progression puzzle. Nature 418 (2002) 823
4. Birchmeier C., Birchmeier W., Gherardi E., and Vande Woude G.F. Met, metastasis, motility and more. Nat Rev Mol Cell Biol 4 (2003) 915-925
5. Blume-Jensen P., and Hunter T. Oncogenic kinase signalling. Nature 411 (2001) 355-365
6. Boardman L.A. Overexpression of MACC1 leads to downstream activation of HGF/MET and potentiates metastasis and recurrence of colorectal cancer. Genome Med 1 (2009) 36
7. Chambers A.F., Groom A.C., and MacDonald I.C. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2 (2002) 563-572
8. Christofori G. New signals from the invasive front. Nature 441 (2006) 444-450
9. Corso S., Comoglio P.M., and Giordano S. Cancer therapy: can the challenge be MET?. Trends Mol Med 11 (2005) 284-292
10. Fearon E.R., and Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 61 (1990) 759-767
11. Fidler I.J. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 3 (2003) 453-458
12. Fodde R., Smits R., and Clevers H. APC, signal transduction and genetic instability in colorectal cancer. Nat Rev Cancer 1 (2001) 55-67
13. Fritzmann J., Morkel M., Besser D., Budczies J., Kosel F., Brembeck F., et al. BAMBI links Wnt/β-catenin and TGFβ signaling in colorectal cancer metastasis. Gastroenterol 137 (2009) 165-175
14. Gavert N., and Ben-Ze'ev A. Epithelial-mesenchymal transition and the invasive potential of tumors. Trends Mol Med 14 (2008) 199-209
15. Kokoszynska K., Krynski J., Rychlewski L., and Wyrwicz L.S. Unexpected domain composition of MACC1 links MET signaling and apoptosis. Acta Biochim Pol 56 (2009) 317-323
16. Millikan K.W., Staren E.D., and Doolas A. Invasive therapy of metastatic colorectal cancer to the liver. Surg Clin North Am 77 (1997) 27-48
17. Naran S., Zhang X., and Hughes S.J. Inhibition of HGF/MET as therapy for malignancy. Expert Opin Ther Targets 13 (2009) 569-581
18. Nguyen D.X., Bos P.D., and Massague J. Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 9 (2009) 274-284
19. O'Connell J.B., Maggard M.A., and Ko C.Y. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst 96 (2004) 1420-1425
20. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 55 (2005) 74-108
21. Sattler M., and Salgia R. c-Met and hepatocyte growth factor: potential as novel targets in cancer therapy. Curr Oncol Rep 9 (2007) 102-108
22. Steeg P.S. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 12 (2006) 895-904
23. Stein U., and Schlag P.M. Clinical, biological, and molecular aspects of metastasis in colorectal cancer. Recent Results Cancer Res 176 (2007) 61-80
24. Stein U., Walther W., Arlt F., Schwabe H., Smith J., Fichtner I., et al. MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis. Nat Med 15 (2009) 59-67
25. Stein U., Smith J., Walther W., and Arlt F. MACC1 controls Met: what a difference an Sp1 site makes. Cell Cycle 8 (2009) 2467-2469
26. Suzuki H., Watkins D.N., Jair K.W., Schuebel K.E., Markowitz S.D., Chen W.D., et al. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet 36 (2004) 417-422